Cargando…
Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement?
PURPOSE: A 2-m axial field-of-view, total-body PET/CT scanner (uEXPLORER) has been recently developed to provide total-body coverage and ultra-high sensitivity, which together, enables opportunities for in vivo time-activity curve (TAC) measurement of all investigated organs simultaneously with high...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282883/ https://www.ncbi.nlm.nih.gov/pubmed/34264416 http://dx.doi.org/10.1186/s40658-021-00395-2 |
_version_ | 1783723085648625664 |
---|---|
author | Hu, Pengcheng Lin, Xin Zhuo, Weihai Tan, Hui Xie, Tianwu Liu, Guobing Chen, Shuguang Chen, Xin Yu, Haojun Zhang, Yiqiu Shi, Hongcheng Liu, Haikuan |
author_facet | Hu, Pengcheng Lin, Xin Zhuo, Weihai Tan, Hui Xie, Tianwu Liu, Guobing Chen, Shuguang Chen, Xin Yu, Haojun Zhang, Yiqiu Shi, Hongcheng Liu, Haikuan |
author_sort | Hu, Pengcheng |
collection | PubMed |
description | PURPOSE: A 2-m axial field-of-view, total-body PET/CT scanner (uEXPLORER) has been recently developed to provide total-body coverage and ultra-high sensitivity, which together, enables opportunities for in vivo time-activity curve (TAC) measurement of all investigated organs simultaneously with high temporal resolution. This study aims at quantifying the cumulated activity and patient dose of 2-[F-18]fluoro-2-deoxy-D-glucose (F-18 FDG ) imaging by using delayed time-activity curves (TACs), measured out to 8-h post-injection, for different organs so that the comparison between quantifying approaches using short-time method (up to 75 min post-injection) or long-time method (up to 8 h post-injection) could be performed. METHODS: Organ TACs of 10 healthy volunteers were collected using total-body PET/CT in 4 periods after the intravenous injection of F-18 FDG. The 8-h post-injection TACs of 6 source organs were fitted using a spline method (based on Origin (version 8.1)). To compare with cumulated activity estimated from spline-fitted curves, the cumulated activity estimated from multi-exponential curve was also calculated. Exponential curve was fitted with shorter series of data consistent with clinical procedure and previous dosimetry works. An 8-h dynamic bladder wall dose model considering 2 voiding were employed to illustrate the differences in bladder wall dose caused by the different measurement durations. Organ absorbed doses were further estimated using Medical Internal Radiation Dose (MIRD) method and voxel phantoms. RESULTS: A short-time measurement could lead to significant bias in estimated cumulated activity for liver compared with long-time-measured spline fitted method, and the differences of cumulated activity were 18.38% on average. For the myocardium, the estimated cumulated activity difference was not statistically significant due to large variation in metabolism among individuals. The average residence time differences of brain, heart, kidney, liver, and lungs were 8.38%, 15.13%, 25.02%, 23.94%, and 16.50% between short-time and long-time methods. Regarding effective dose, the maximum differences of residence time between long-time-measured spline fitted curve and short-time-measured multi-exponential fitted curve was 9.93%. When using spline method, the bladder revealed the most difference in the effective dose among all the investigated organs with a bias up to 21.18%. The bladder wall dose calculated using a long-time dynamic model was 13.79% larger than the two-voiding dynamic model, and at least 50.17% lower than previous studies based on fixed bladder content volume. CONCLUSIONS: Long-time measurement of multi-organ TACs with high temporal resolution enabled by a total-body PET/CT demonstrated that the clinical procedure with 20 min PET scan at 1 h after injection could be used for retrospective dosimetry analysis in most organs. As the bladder content contributed the most to the effective dose, a long-time dynamic model was recommended for the bladder wall dose estimation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40658-021-00395-2. |
format | Online Article Text |
id | pubmed-8282883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-82828832021-07-20 Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement? Hu, Pengcheng Lin, Xin Zhuo, Weihai Tan, Hui Xie, Tianwu Liu, Guobing Chen, Shuguang Chen, Xin Yu, Haojun Zhang, Yiqiu Shi, Hongcheng Liu, Haikuan EJNMMI Phys Original Research PURPOSE: A 2-m axial field-of-view, total-body PET/CT scanner (uEXPLORER) has been recently developed to provide total-body coverage and ultra-high sensitivity, which together, enables opportunities for in vivo time-activity curve (TAC) measurement of all investigated organs simultaneously with high temporal resolution. This study aims at quantifying the cumulated activity and patient dose of 2-[F-18]fluoro-2-deoxy-D-glucose (F-18 FDG ) imaging by using delayed time-activity curves (TACs), measured out to 8-h post-injection, for different organs so that the comparison between quantifying approaches using short-time method (up to 75 min post-injection) or long-time method (up to 8 h post-injection) could be performed. METHODS: Organ TACs of 10 healthy volunteers were collected using total-body PET/CT in 4 periods after the intravenous injection of F-18 FDG. The 8-h post-injection TACs of 6 source organs were fitted using a spline method (based on Origin (version 8.1)). To compare with cumulated activity estimated from spline-fitted curves, the cumulated activity estimated from multi-exponential curve was also calculated. Exponential curve was fitted with shorter series of data consistent with clinical procedure and previous dosimetry works. An 8-h dynamic bladder wall dose model considering 2 voiding were employed to illustrate the differences in bladder wall dose caused by the different measurement durations. Organ absorbed doses were further estimated using Medical Internal Radiation Dose (MIRD) method and voxel phantoms. RESULTS: A short-time measurement could lead to significant bias in estimated cumulated activity for liver compared with long-time-measured spline fitted method, and the differences of cumulated activity were 18.38% on average. For the myocardium, the estimated cumulated activity difference was not statistically significant due to large variation in metabolism among individuals. The average residence time differences of brain, heart, kidney, liver, and lungs were 8.38%, 15.13%, 25.02%, 23.94%, and 16.50% between short-time and long-time methods. Regarding effective dose, the maximum differences of residence time between long-time-measured spline fitted curve and short-time-measured multi-exponential fitted curve was 9.93%. When using spline method, the bladder revealed the most difference in the effective dose among all the investigated organs with a bias up to 21.18%. The bladder wall dose calculated using a long-time dynamic model was 13.79% larger than the two-voiding dynamic model, and at least 50.17% lower than previous studies based on fixed bladder content volume. CONCLUSIONS: Long-time measurement of multi-organ TACs with high temporal resolution enabled by a total-body PET/CT demonstrated that the clinical procedure with 20 min PET scan at 1 h after injection could be used for retrospective dosimetry analysis in most organs. As the bladder content contributed the most to the effective dose, a long-time dynamic model was recommended for the bladder wall dose estimation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40658-021-00395-2. Springer International Publishing 2021-07-15 /pmc/articles/PMC8282883/ /pubmed/34264416 http://dx.doi.org/10.1186/s40658-021-00395-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Research Hu, Pengcheng Lin, Xin Zhuo, Weihai Tan, Hui Xie, Tianwu Liu, Guobing Chen, Shuguang Chen, Xin Yu, Haojun Zhang, Yiqiu Shi, Hongcheng Liu, Haikuan Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement? |
title | Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement? |
title_full | Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement? |
title_fullStr | Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement? |
title_full_unstemmed | Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement? |
title_short | Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement? |
title_sort | internal dosimetry in f-18 fdg pet examinations based on long-time-measured organ activities using total-body pet/ct: does it make any difference from a short-time measurement? |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282883/ https://www.ncbi.nlm.nih.gov/pubmed/34264416 http://dx.doi.org/10.1186/s40658-021-00395-2 |
work_keys_str_mv | AT hupengcheng internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement AT linxin internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement AT zhuoweihai internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement AT tanhui internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement AT xietianwu internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement AT liuguobing internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement AT chenshuguang internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement AT chenxin internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement AT yuhaojun internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement AT zhangyiqiu internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement AT shihongcheng internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement AT liuhaikuan internaldosimetryinf18fdgpetexaminationsbasedonlongtimemeasuredorganactivitiesusingtotalbodypetctdoesitmakeanydifferencefromashorttimemeasurement |